3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
23
Sarcoma
9
Dermatologic
3
Thoracic
2
Lymphoid
2
Head & Neck
2
Gynecologic
2
Gastrointestinal
2
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Genitourinary
1
Endocrine
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Leukemia
16
Lymphoma, Non-Hodgkin
9
Lymphoma
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, Mantle-Cell
6
Lymphoma, B-Cell, Marginal Zone
6
Lymphoma, Follicular
5
Burkitt Lymphoma
5
Recurrence
4
Neoplasms
4
Myelodysplastic Syndromes
4
Lymphoma, Large-Cell, Anaplastic
4
Congenital Abnormalities
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Extranodal NK-T-Cell
3
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Immunoblastic Lymphadenopathy
3
Hematologic Neoplasms
3
Thrombocythemia, Essential
2
Sezary Syndrome
2
Primary Myelofibrosis
2
Interventions
Paclitaxel
2
Azacitidine
2
temsirolimus
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pembrolizumab
1
fludarabine
1
ceritinib
1
cc-486
1
carboxyamido-triazole
1
bemcentinib
1
acalabrutinib
1
abiraterone
1
Uncertainty
1
Thalidomide
1
Temozolomide
1
Sorafenib
1
Quality of Life
1
Psychosocial Intervention
1
Patient Reported Outcome Measures
1
Oxaliplatin
1
O(6)-benzylguanine
1
Molecular Diagnostic Techniques
1
Leucovorin
1
Lenalidomide
1
Interleukin-2
1
Interleukin-15
1
Injections
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Drug Therapy
×
Other hematologic neoplasm
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled